收稿日期: 2020-07-01
网络出版日期: 2022-06-28
Application of high performance liquid chromatography (HPLC) and erythrocyte parameters in the screening of hemoglobinopathy
Received date: 2020-07-01
Online published: 2022-06-28
目的:探讨高效液相色谱(high performance liquid chromatography, HPLC)技术和红细胞参数在血红蛋白(hemoglobin, Hb)病筛查中的实际应用价值。方法:应用HPLC技术对1 029例临床疑似Hb病患者及进行溶血性贫血筛查者的血样本进行Hb分析,同时采用缺口聚合酶链反应、反向斑点杂交和珠蛋白基因DNA测序对样本进行基因分析;记录并分析患者的血常规红细胞参数。结果:1 029例血样本中,有591例(57.43%)确诊为珠蛋白生成障碍性贫血,14例(1.36%)确诊为异常Hb病。以基因分析结果为诊断金标准,应用HPLC检测β-珠蛋白生成障碍性贫血,以血红蛋白A2(hemoglobin A2, HbA2)3.9%为临界值, HbA2>3.9%诊断β-珠蛋白生成障碍性贫血的灵敏度为95.84%,特异度为96.87%,阳性预测值为95.40%,阴性预测值为97.20%,受试者操作特征曲线下面积(area under curve, AUC)为0.962;以HbA2 2.1%为临界值,HbA2≤2.1%结合出现快速区带来诊断中间型α-珠蛋白生成障碍性贫血[又称血红蛋白H(hemoglobin H, HbH)病]的灵敏度为100.00%,特异度为96.32%,阳性预测值为52.60%,阴性预测值为100.00%,AUC为0.990;以HbA2 3.2%为临界值,HbA2≤3.2%诊断静止型和标准型α-珠蛋白生成障碍性贫血的灵敏度为97.76%,特异度为53.11%,阳性预测值为24.0%,阴性预测值为99.4%,AUC为0.753。分别以平均红细胞体积(mean corpuscular volume, MCV)≤73.3 fl,平均红细胞血红蛋白量(mean corpuscular hemoglobin, MCH)≤23.5 pg,平均红细胞血红蛋白浓度(mean corpuscular hemoglobin contentration, MCHC)≤324 g/L诊断珠蛋白生成障碍性贫血,其灵敏度和特异度分别为87.98%和77.51%,93.73%和69.86%,89.20%和47.61%。结论:在红细胞参数测定的基础上,应用HPLC检测筛查β-珠蛋白生成障碍性贫血、HbH病和异常Hb病的灵敏度、特异度高,与基因分析结果间有较高的一致性,且操作简便、快速,适用于临床快速筛查;但对于静止型和标准型α-珠蛋白生成障碍性贫血,HPLC检测的筛查特异度和阳性预测值均较低,易造成漏诊。
王也飞, 吴蓓颖, 夏文权, 陈宁, 胡翊群 . 高效液相色谱技术联合红细胞参数在血红蛋白病筛查中的应用[J]. 诊断学理论与实践, 2021 , 20(03) : 271 -278 . DOI: 10.16150/j.1671-2870.2021.03.008
Objective: To explore the application value of high performance liquid chromatography (HPLC) and erythrocyte parameters for screening of thalassemia in Shanghai. Methods: The hemoglobin of 1 029 samples from patients with suspected thalassemia and with suspected hemolytic anemia were analyzed using HPLC. Genetic analysis of the globin were performed simultaneously with GAP-PCR,reverse dot blot(RDB) and DNA sequencing. Results: Among 1029 samples, 591(57.43%) were diagnosed as having thalassemia and 14 (1.36%) having structural hemoglobin variants.Compared with results of genetic analysis,the sensitivity,specificity,positive predictive value and negative predictive value of HbA2 >3.9% by HPLC as cut-off value for diagnosing β-thalassemia were 95.84%, 96.87%, 95.40%, 97.20%,with AUC of 0.962. When HbA2≤2.1% by HPLC as the cutoff value combined with presence of rapid band were taken for diagnosing α-thalassemia moderate(HbH disease), sensitivity, specificity, positive predictive value, negative predictive value were 96.32%, 52.60%, 100.00 %, with AUC of 0.990. If f HbA2 ≤3.2% by HPLC was taken as the cutoff value for diagnosing minor α-thalassemia or α-thalassemia trait, the corresponding indice were 97.76%, 53.11%, 24.0%, 99.4%,and AUC was 0.753. If MCV≤73.3 fl,MCH≤23.5 pg,MCHC≤324g/L were taken as the cutoff value alone for diagnosing thalassemia, sensitivity and specificity were 87.98%,77.51%, 93.73% and 69.86%, 89.20%,47.61%,respectively. Conclusions: Based on RBC parameters analysis,results of HPLC technology have a good consistence with the resluts of gene detection in the diagnosis of β-thalassemia, HbH disease and structural hemoglobin variant, while a low specificity and positive predictive value may occur in the diagnosis of minor α-thalassemia orα-thalassemia trait.
[1] | 中华医学会儿科学分会血液学组, 《中华儿科杂志》编辑委员会. 重型β地中海贫血的诊断和治疗指南(2017年版)[J]. 中华儿科杂志, 2018, 56(10):724-729. |
[2] | 梁栋伟, 张振洪, 黄勤, 等. 异常血红蛋白病红细胞形态的研究[J]. 检验医学与临床, 2015, 12(12):1764-1765. |
[3] | 冯桂玲, 林桢, 林敏, 等. ROC曲线评价β地中海贫血血红蛋白A2的诊断价值[J]. 实用医学杂志, 2013, 29(13):2187-2189. |
[4] | 曾劲伟, 杨光, 崔金环, 等. 高效液相色谱法检测血红蛋白A2诊断β-地中海贫血携带者的最佳阈值[J]. 中国循证医学杂志, 2009, 9(8):828-831. |
[5] | 谢建红, 张永良, 肖奇志, 等. 应用高效液相色谱法检测β-地中海贫血及异常血红蛋白[J]. 广东医学, 2011, 32(11):1473-1476. |
[6] | 李东明, 韦媛, 何升, 等. 高效液相色谱分析筛查地中海贫血32638例分析[J]. 现代仪器与医疗, 2014, 20(5):38-40. |
[7] | 何天文, 余丽华, 郭浩, 等. ROC曲线分析血红蛋白A2筛查地中海贫血的价值[J]. 中国实验血液学杂志, 2016, 24(6):1828-1832. |
[8] | 彭建宏, 刘运科, 肖春燕. 离子交换高效液相色谱法血红蛋白分析筛查地中海贫血的研究[J]. 国际医药卫生导报, 2012, 18(4):539-543. |
[9] | 蒋美秀. 地贫筛查的进展及重要性[J]. 世界最新医学信息文摘, 2015, 15(7):33-35. |
[10] | 陈雅斌, 蒋燕成, 陈紫萱, 等. HbA2筛查地中海贫血诊断界值的建立及其与MCV、MCH联合筛查的价值[J]. 检验医学, 2019, 34(4):318-321. |
[11] | 马升俊, 肖永君, 韦子斌, 等. 全自动血红蛋白分析仪在地中海贫血筛查诊断中的应用[J]. 医学检验, 2013, 10(9):92-93,96. |
/
〈 |
|
〉 |